The screening period will help determine your eligibility to participate, make general and disease-specific health assessments, and provide baseline testing results to compare with the end of treatment. You will also have physical examinations and laboratory tests, if needed, to make sure you are healthy enough and ready to participate. These include, but are not limited to, an ECG, an MRI, and a genetic test to confirm a mutation of the FUS gene.
Because this is a research study, if, after you have completed some or all of the examinations required during the screening period, you may or may not be eligible to participate in the FUSION study.
